Financial reports
ARS
2023 FY
Annual report to shareholders
15 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 Feb 24
8-K
Other Events
31 Jan 24
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Entry into a Material Definitive Agreement
27 Nov 23
8-K
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
6 Nov 23
8-K
Entry into a Material Definitive Agreement
16 Oct 23
8-K
Entry into a Material Definitive Agreement
4 Oct 23
8-K
Entry into a Material Definitive Agreement
7 Sep 23
8-K
Vaxcyte Reports Second Quarter 2023 Financial Results and Provides Business Update
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
27 Feb 24
424B5
Prospectus supplement for primary offering
31 Jan 24
424B5
Prospectus supplement for primary offering
30 Jan 24
424B5
Prospectus supplement for primary offering
20 Apr 23
424B5
Prospectus supplement for primary offering
17 Apr 23
424B5
Prospectus supplement for primary offering
27 Feb 23
S-8
Registration of securities for employees
27 Feb 23
S-3ASR
Automatic shelf registration
22 Dec 22
424B5
Prospectus supplement for primary offering
26 Oct 22
424B5
Prospectus supplement for primary offering
24 Oct 22
Proxies
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
20 Apr 22
DEF 14A
Definitive proxy
20 Apr 22
DEFA14A
Additional proxy soliciting materials
14 Apr 21
DEF 14A
Definitive proxy
14 Apr 21
Other
EFFECT
Notice of effectiveness
12 Jun 20
CERT
Certification of approval for exchange listing
10 Jun 20
CORRESP
Correspondence with SEC
9 Jun 20
CORRESP
Correspondence with SEC
9 Jun 20
CORRESP
Correspondence with SEC
22 May 20
UPLOAD
Letter from SEC
27 Mar 20
UPLOAD
Letter from SEC
21 Jan 20
UPLOAD
Letter from SEC
8 Nov 19
Ownership
144
Notice of proposed sale of securities
23 Apr 24
4
ANDREW GUGGENHIME
22 Apr 24
4
Jim Wassil
19 Apr 24
144
Notice of proposed sale of securities
18 Apr 24
4
Mikhail Eydelman
3 Apr 24
4
Jim Wassil
3 Apr 24
4
GRANT PICKERING
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24